Adv. Dr. Amir Shavitzky

Dr. Shavitzky acts for his clients in a variety of cross-border and domestic corporate transactions, including mergers and acquisitions, equity and debt financings

Dr. Shavitzky represents public and private companies and leading business people and investors. He is actively involved in the on-going business and activities of his clients, be it advising with respect to purchase/sale transactions, distribution agreements, marketing agreements, licensing agreements, equity and debt financing agreements, joint venture agreements etc. Dr. Shavitzky also regularly advises boards and managements of public and private companies on corporate governance matters.

Dr. Shavitzky’s top goal is to assist his clients in achieving their business objectives, while always protecting their interests. To that end, Dr. Shavitzky works closely with his clients, understanding their businesses, plans and targets. He places significant emphasis on offering creative legal advice that is tailored to the specific situation with respect to which he is counseling.

Dr. Shavitzky has extensive experience and expertise in M&A and other commercial transactions. He is actively involved in all stages of a transaction, from planning the transaction structure, drafting the agreements, negotiating, up to completion of the transaction. He works closely with his clients throughout negotiations, identifying solutions to complex issues, while never losing sight of the clients’ commercial objectives.

Dr. Shavitzky completed his legal studies with distinction at the Hebrew University of Jerusalem, after which he received his masters in law from Columbia University. Dr. Shavitzky earned his doctorate in law from Illinois University Law School, where his research focused on questions relating to monetarily quantifying pain-and-suffering damages using psychological and economic studies. Dr. Shavitzky clerked for the Deputy Chief Justice of the Supreme Court of Israel, Justice Eliezer Rivlin.

Representative Transactions

• Representation of the Paz Group (TASE: PZOL) in connection with a capital investment made into Paz Ashdod Refinery Ltd. (PAZA) by Shapir (with a valuation given to PAZA of NIS 1.4 billion, prior to the capital investment made by Shapir).
• Representation of the Politiv Group in connection with a capital investment made in the company by Kedma Capital.
• Representation of the Israel Aerospace Industries in a transaction to purchase shares of an engineering company.
• Representation of Carvil Ltd. in connection with the capital investment made in the company by Harbour Group International.
• Representation of the fintech company Pagaya in the purchase from Meitav Dash of its interests in an investment fund operating in the USA.
• Representation of the Board of Directors of Paz Oil Company Ltd. in connection with its examination of several unsolicited proposals (including a proposal by Shikun & Binui and a proposal by Leumi Partners) for the acquisition of a control stake in, or merger with, Paz Oil Company Ltd.
• Representation of Unitask Ltd. in its sale to EMET Computing Ltd., a public company.
• Representation of M.A. MedAlliance in its $50 million financing round, with CITIC Capital Partners acting as lead investor.
• Representation of Impulse Dynamics N.V. in its $80 million financing round, with Amzak Health and Wellington Management acting as lead investors.
• Representation of the Lahav LR Group in the sale of its entire shareholding in SolGreen, a solar energy company, to Generation Capital.
• Representation of a medical device company in a $25 million loan facility from Kennedy Lewis Investment Management.
• Representation of the controlling shareholder in Starkist Ltd., which holds an exclusive license from Kraft Heinz to distribute in Israel all products under the Starkist brand name, in the sale of the company to the Diplomat Group.
• Representation of Impulse Dynamics N.V. in its $45 million financing round, with Goldstone Investment, a global investment company owned by the Chinese conglomerate CITIC Securities acting as lead investor.
• Representation of an investment fund of China Development Bank and Shanghai Gongbao, a Chinese investment group, as possible acquirers, in the selling process of the controlling stake of Clal Insurance by the IDB Group.
• Representation of Mr. Moti Ben Moshe and ExtraEnergie GmbH, Germany, in acquiring the controlling stake in the IDB Group, one of the largest and diverse Israeli conglomerates. Such acquisition was made as part of a court supervised debt arrangement surrounding the IDB Group (under the previous controlling shareholder) initiated by the Group’s creditors.
• Representation of the MedInvest Group and several of its portfolio companies in a $130 million loan facility with The European Investment Bank as lead lender and Morgan Stanley Bank International Limited acting as agent.
• Representation of Plimus Inc. in its sale to private equity fund Great Hill Partners for $115 million.
• Representation of the controlling shareholder in Compulab Limited in the disposition of his stake in the company to an investment group led by TechnoPlus Ventures Limited.
• Representation of Politiv Limited in a joint venture transaction relating to the establishment of a polyethylene sheets factory in Mexico.
• Representation of Amitim – Pension Funds, one of Israel’s largest institutional entities, in several investments made in the USA and Israel.
• Representation of CRG Electronics Limited in the sale of its electronic components distribution business to Avnet Inc. (NYSE:AVT).
• Representation of the Politiv Group in acquiring the business of Meteor Agricultural Nets Limited.
• Representation of Foamotive (part of the Palziv Group) in the establishment in Mexico of a plant which produces foam parts for the automotive industry.